Global Surgical Glue Market Size Likely to Reach at a CAGR of 7.1% By 2033

Global Surgical Glue Market size was valued at USD 3.8 Billion in 2024 and is expected to reach USD 11.4 Billion by 2033, at a CAGR of 7.1% during the forecast period 2024 – 2033.

Surgical Glue Market: Overview

Surgical glue is a type of adhesive used in surgical procedures to close wounds, incisions, or lacerations. It is applied topically to the skin or tissues and forms a bond that holds the wound edges together, promoting healing and reducing the risk of infection.

Global trends in the surgical glue market are shaped by technological advancements, increasing demand for minimally invasive procedures, and growing awareness of infection prevention. There is a notable shift towards bio-based and biodegradable adhesive formulations to meet sustainability goals and minimize environmental impact.

Additionally, the rise in chronic diseases and age-related surgeries is driving the demand for surgical glue as a convenient wound closure solution. Moreover, the growing emphasis on infection control and patient safety is leading to the development of surgical glues with antimicrobial properties.

Furthermore, advancements in adhesive technologies, such as stronger bonding capabilities and faster curing times, are enhancing the efficacy and reliability of surgical glue products. Overall, the surgical glue market is witnessing a trajectory towards innovative, sustainable, and patient-centric solutions to meet the evolving needs of healthcare providers and patients worldwide.

By type, the synthetic glue segment held the highest market share in 2022 and is expected to keep its dominance during the forecast period 2024-2032. A key trend in synthetic surgical glue is the development of advanced formulations with enhanced properties such as improved adhesion strength, biocompatibility, and biodegradability. Additionally, there is a focus on incorporating antimicrobial agents into synthetic glues to reduce the risk of post-operative infections and improve patient outcomes.

By application, cardiovascular surgeries segment held the highest market share in 2022 and is expected to keep its dominance during the forecast period 2024-2032. Cardiovascular surgeries drive the surgical glue market due to the complexity and delicate nature of procedures, where precise closure of blood vessels and tissues is critical.

By end user, the hospitals segment held the highest market share in 2022 and is expected to keep its dominance during the forecast period 2024-2032. Hospitals drive the surgical glue market due to the increasing demand for efficient wound closure solutions. Surgical glue offers several advantages over traditional methods such as sutures, including faster application, reduced scarring, and improved patient comfort

North America drives the surgical glue market due to factors such as advanced healthcare infrastructure, high prevalence of chronic diseases necessitating surgeries, increasing demand for minimally invasive procedures, and rising awareness regarding infection prevention. Moreover, substantial investments in medical research and development contribute to market growth in the region.

CryoLife, Inc., a prominent medical device and tissue processing firm specializing in cardiac and vascular surgery, has initiated enrollment for its BioGlue clinical trial in China. The trial outcomes will form the foundation for the company’s submission to the Chinese Food and Drug Administration (CFDA) for BioGlue commercialization approval in China.

Report Scope

CMI has comprehensively analyzed surgical glue market. The driving forces, restraints, challenges, opportunities, and key trends have been explained in depth to depict in depth scenario of the market. Segment wise market size and market share during the forecast period are duly addressed to portray the probable picture of this surgical glue industry.

The competitive landscape includes key innovators, after market service providers, market giants as well as niche players are studied and analyzed extensively concerning their strengths, weaknesses as well as value addition prospects. In addition, this report covers key players profiling, market shares, mergers and acquisitions, consequent market fragmentation, new trends and dynamics in partnerships.

List of the prominent players in the Surgical Glue Market:

• Ethicon Inc.
• Baxter International Inc.
• Medtronic plc
• Braun Melsungen AG
• 3M Company
• CryoLife Inc.
• Cardinal Health Inc.
• Cohera Medical Inc.
• Takeda Pharmaceutical Company Limited
• Chemence Medical Inc.
• Integra LifeSciences Corporation
• Advanced Medical Solutions Group plc
• Meyer-Haake GmbH Medical Innovations
• Adhezion Biomedical LLC
• GluStitch Inc.
• HyperBranch Medical Technology Inc.
• Johnson & Johnson Services Inc.
• Tissuemed Ltd.
• Luna Innovations Incorporated
• R. Bard Inc.
• Others

The Surgical Glue Market is segmented as follows:

By Type

• Natural
• Synthetic

By Application

• Nervous System Surgeries
• General Surgeries
• Cardiovascular Surgeries
• Orthopedic Surgeries
• Cosmetic Surgeries
• Ophthalmic Surgeries
• Urological Surgeries
• Pulmonary Surgeries
• Others

By End User

• Hospitals
• Clinics
• Others

Regional Coverage:

North America

• U.S.
• Canada
• Mexico
• Rest of North America

Europe

• Germany
• France
• U.K.
• Russia
• Italy
• Spain
• Netherlands
• Rest of Europe

Asia Pacific

• China
• Japan
• India
• New Zealand
• Australia
• South Korea
• Taiwan
• Rest of Asia Pacific

The Middle East & Africa

• Saudi Arabia
• UAE
• Egypt
• Kuwait
• South Africa
• Rest of the Middle East & Africa

Latin America

• Brazil
• Argentina
• Rest of Latin America